Improving HIV prevention care for women in community health clinics in the Southern U.S.
Implementation and Dissemination of Evidence-Based Interventions to Improve PrEP Care Continuum Outcomes Among Women in Community Health Clinics in the Southern U.S.
This study is working to help more women, especially Black women in the Southern U.S., access and stay on PrEP, a medication that helps prevent HIV, by providing better education and support in community health clinics.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10875463 on NIH RePORTER |
What this research studies
This research aims to address the significant disparities in pre-exposure prophylaxis (PrEP) usage among cisgender women, particularly Black women in the Southern U.S. The project will implement evidence-based interventions to enhance the PrEP care continuum, focusing on education, provider training, and the use of electronic medical records to identify and support women at high risk for HIV. By utilizing successful strategies previously tested in other regions, the research seeks to improve PrEP uptake and retention among women in community health clinics. Patients will benefit from tailored support and resources designed to empower them in their HIV prevention journey.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black cisgender women living in the Southern U.S. who are at high risk for HIV.
Not a fit: Patients who are not cisgender women or those who do not reside in the Southern U.S. may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase PrEP usage and retention among women, particularly Black women, thereby reducing new HIV infections.
How similar studies have performed: Previous research has shown success in increasing PrEP uptake among men and transgender women, but this approach specifically targeting Black cisgender women is novel.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Ridgway, Jessica — University of Chicago
- Study coordinator: Ridgway, Jessica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.